NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-133-2015-0-US-07 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE US National Stage 15/772,443 11236152 Issued PDF
NCI E-109-2016-0-US-03 TARGETED CANCER THERAPY US National Stage 15/772,134 11207339 Issued PDF
NCATS E-050-2012-0-AU-12 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases AU DIV 2018202964 Issued
NCI E-108-2016-0-US-03 Papillomavirus Virus-like Particles For Increasing The Effectiveness And Safety Of CAR-based Adoptive Cell Therapy Of Cancer US National Stage 15/772,152 Abandoned
NIEHS E-125-2018-0-US-01 Targeting Epithelial Membrane Protein 2 To Protect Respiratory Epithelial Barrier Integrity During Lung Infection And Inflammation US 62/664,805 Abandoned
NCI E-187-2015-0-US-07 COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS US National Stage 15/771,932 11266726 Issued PDF
NCI E-256-2008-0-US-13 SURVIVAL PREDICTOR FOR DIFFUSE LARGE B CELL LYMPHOMA US CON 15/965,510 11028444 Issued PDF
NCI E-103-2021-0-US-01 Use Of Lentivector - Transduced T-RAPA Cells For Amelioration Of Lysosomal Storage Disorders US 62/663,786 Abandoned
NHLBI E-222-2022-2-US-01 Catheters and Manipulators with Deflectable Ends US 62/663,518 Expired
NCATS E-198-2016-0-EP-05 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling EP National Stage 18790880.1 Issued
NCATS E-198-2016-0-FR-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling FR EP 18790880.1 Issued
NCATS E-198-2016-0-DE-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling DE EP 18790880.1 Issued
NCATS E-198-2016-0-GB-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling GB EP 18790880.1 Issued
NCATS E-198-2016-0-CN-06 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling CN National Stage 201880042610.4 Issued
NCATS E-198-2016-0-JP-07 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling JP National Stage 2019-558704 Issued
NCI E-059-2013-0-JP-10 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP DIV 2018-085761 Issued
NCATS E-198-2016-0-PCT-02 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling PCT PCT PCT/US2018/029626 Expired
NCI E-128-2017-0-PCT-02 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS PCT PCT PCT/US2018/029623 Expired
NCI E-128-2017-0-EP-03 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS EP National Stage 18724092.4 Pending
NCATS E-198-2016-0-CA-03 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling CA National Stage 3059232 Pending
NIMH E-126-2018-0-US-01 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF US 62/663,085 Abandoned
NIAID E-001-2017-1-PCT-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION PCT PCT COMB PCT/US2018/029463 Expired
NIAID E-001-2017-1-EP-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP National Stage 18724410.8 Pending
NHLBI E-165-2015-1-EP-02 Lentiviral Protein Delivery System For RNA-guided Genome Editing EP National Stage 16782163.6 Issued
NHLBI E-165-2015-1-FR-05 Lentiviral Protein Delivery System For RNA-guided Genome Editing FR EP 16782163.6 Issued
NHLBI E-165-2015-1-DE-04 Lentiviral Protein Delivery System For RNA-guided Genome Editing DE EP 16782163.6 Issued
NHLBI E-165-2015-1-GB-06 Lentiviral Protein Delivery System For RNA-guided Genome Editing GB EP 16782163.6 Issued
NHLBI E-165-2015-1-CH-03 Lentiviral Protein Delivery System For RNA-guided Genome Editing CH EP 16782163.6 Issued
NHLBI E-165-2015-1-IE-07 Lentiviral Protein Delivery System For RNA-guided Genome Editing IE EP 16782163.6 Issued
NIAID E-449-2013-1-US-06 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING US CON 15/961,554 10383960 Abandoned PDF
NCI E-094-2018-0-US-01 METHODS OF PRODUCING T CELL POPULATIONS USING A HYDROXCITRATE SALT US 62/661,941 Abandoned
NCI E-266-2015-0-US-04 Process For Preparing Z-endoxifen Of High Purity US National Stage 15/770,274 10464881 Issued PDF
NIAID E-052-2017-4-US-45 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection US National Stage 15/770,471 Abandoned
NHLBI E-152-2018-0-EP-04 Fluorogen-binding RNA Aptamers EP National Stage 18725646.6 Pending
NCATS E-193-2018-0-US-01 Systemic CRISPR Therapy US 62/661,391 Abandoned
NCI E-122-2018-0-US-01 COMPOSITIONS AND METHODS FOR MODULATING ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION US 62/661,234 Abandoned
NIAID E-018-2018-0-US-01 CHIMERIC VECTORS US 62/661,320 Abandoned
NHLBI E-152-2018-0-CA-03 Fluorogen-binding RNA Aptamers CA National Stage 3060379 Pending
NHLBI E-152-2018-0-PCT-02 Fluorogen-binding RNA Aptamers PCT PCT PCT/IB2018/052808 Expired
NHLBI E-152-2018-0-NZ-01 Fluorogen-binding RNA Aptamers NZ National Stage 758304 Pending
NICHD E-211-2021-0-US-02 Systems And Methods To Predict Risk For Preterm Labor And/or Preterm Birth US ORD 15/958,959 10802030 Issued PDF
NCI E-039-2017-0-US-03 Phenyl Indole Allosteric Inhibitors Of P97 ATPase US National Stage 15/769,987 10633370 Issued PDF
NIDDK E-213-2015-0-EP-04 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS EP National Stage 16774825.0 Issued
NIDDK E-213-2015-0-GB-08 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS GB EP 16774825.0 Issued
NIDDK E-213-2015-0-DE-06 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS DE EP 16774825.0 Issued
NIDDK E-213-2015-0-FR-07 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS FR EP 16774825.0 Issued
NEI E-119-2017-0-US-03 IL-24 TO TREAT INFLAMMATORY DISEASES US ORD 15/957,019 10512671 Issued PDF
NCI E-066-2015-0-US-03 BIODOSIMETRY ANALYSIS US National Stage 15/769,718 Abandoned
NICHD E-062-2015-0-US-03 Codon-optimized Reduced-size ATP7A Complementary DNA And Uses for Treatment of Copper Transport Disorders US National Stage 15/769,294 10988778 Issued PDF
NINDS E-143-2002-1-US-77 Zenapax (Humanized Antibody Against The IL-2 Receptor Alpha Chain) As A Novel Treatment For Multiple Sclerosis US CON 15/956,458 Abandoned